Literature DB >> 30195831

Comprehensive effects of left ventricular assist device speed changes on alveolar gas exchange, sleep ventilatory pattern, and exercise performance.

Anna Apostolo1, Stefania Paolillo2, Mauro Contini1, Carlo Vignati3, Vincenzo Tarzia4, Jeness Campodonico1, Massimo Mapelli1, Massimo Massetti5, Jonida Bejko4, Francesca Righini1, Tomaso Bottio4, Niccolò Bonini1, Elisabetta Salvioni1, Paola Gugliandolo1, Gianfranco Parati6, Carolina Lombardi7, Gino Gerosa4, Luca Salvi1, Francesco Alamanni1, Piergiuseppe Agostoni8.   

Abstract

BACKGROUND: Increasing left ventricular assist device (LVAD) pump speed according to the patient's activity is a fascinating hypothesis. This study analyzed the short-term effects of LVAD speed increase on cardiopulmonary exercise test (CPET) performance, muscle oxygenation (near-infrared spectroscopy), diffusion capacity of the lung for carbon monoxide (Dlco) and nitric oxide (Dlno), and sleep quality.
METHODS: We analyzed CPET, Dlco and Dlno, and sleep in 33 patients supported with the Jarvik 2000 (Jarvik Heart Inc., New York, NY). After a maximal CPET (n = 28), patients underwent 2 maximal CPETs with LVAD speed randomly set at 3 or increased from 3 to 5 during effort (n = 15). Then, at LVAD speed randomly set at 2 or 4, we performed (1) constant workload CPETs assessing O2 kinetics, cardiac output (CO), and muscle oxygenation (n = 15); (2) resting Dlco and Dlno (n = 18); and (3) nocturnal cardiorespiratory monitoring (n = 29).
RESULTS: The progressive pump speed increase raised peak volume of oxygen consumption (12.5 ± 2.5 ml/min/kg vs 11.7 ± 2.8 ml/min/kg at speed 3; p = 0.001). During constant workload, from speed 2 to 4, CO increased (at rest: 3.18 ± 0.76 liters/min vs 3.69 ± 0.75 liters/min, p = 0.015; during exercise: 5.91 ± 1.31 liters/min vs 6.69 ± 0.99 liters/min, p = 0.014), and system efficiency (τ = 65.8 ± 15.1 seconds vs 49.9 ± 14.8 seconds, p = 0.002) and muscle oxygenation improved. At speed 4, Dlco decreased, and obstructive apneas increased despite a significant apnea/hypopnea index and a reduction of central apneas.
CONCLUSIONS: Short-term LVAD speed increase improves exercise performance, CO, O2 kinetics, and muscle oxygenation. However, it deteriorates lung diffusion and increases obstructive apneas, likely due to an increase of intrathoracic fluids. Self-adjusting LVAD speed is a fascinating but possibly unsafe option, probably requiring a monitoring of intrathoracic fluids.
Copyright © 2018 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CPET; LVAD; cardiac output; exercise; lung diffusion; muscle oxygenation

Mesh:

Substances:

Year:  2018        PMID: 30195831     DOI: 10.1016/j.healun.2018.07.005

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  8 in total

Review 1.  Physiology of the Assisted Circulation in Cardiogenic Shock: A State-of-the-Art Perspective.

Authors:  Julien Guihaire; Francois Haddad; Mita Hoppenfeld; Myriam Amsallem; Jeffrey W Christle; Clark Owyang; Khizer Shaikh; Joe L Hsu
Journal:  Can J Cardiol       Date:  2019-11-09       Impact factor: 5.223

Review 2.  Approaches to improving exercise capacity in patients with left ventricular assist devices: an area requiring further investigation.

Authors:  Richard Severin; Ahmad Sabbahi; Cemal Ozemek; Shane Phillips; Ross Arena
Journal:  Expert Rev Med Devices       Date:  2019-09-06       Impact factor: 3.166

3.  Marginal versus Standard Donors in Heart Transplantation: Proper Selection Means Heart Transplant Benefit.

Authors:  Olimpia Bifulco; Tomaso Bottio; Raphael Caraffa; Massimiliano Carrozzini; Alvise Guariento; Jonida Bejko; Marny Fedrigo; Chiara Castellani; Giuseppe Toscano; Giulia Lorenzoni; Vincenzo Tarzia; Dario Gregori; Massimo Cardillo; Francesca Puoti; Giuseppe Feltrin; Annalisa Angelini; Gino Gerosa
Journal:  J Clin Med       Date:  2022-05-09       Impact factor: 4.964

Review 4.  Exercise Dynamic of Patients with Chronic Heart Failure and Reduced Ejection Fraction.

Authors:  Sara Rovai; Irene Mattavelli; Elisabetta Salvioni; Ugo Corrà; Gaia Cattadori; Jeness Campodonico; Simona Romani; Piergiuseppe Agostoni
Journal:  Curr Cardiol Rep       Date:  2021-06-29       Impact factor: 2.931

Review 5.  Left Ventricular Assist Device Support Complicates the Exercise Physiology of Oxygen Transport and Uptake in Heart Failure.

Authors:  Erik H Van Iterson
Journal:  Card Fail Rev       Date:  2019-11-04

6.  Real-Time Ventricular Volume Measured Using the Intracardiac Electromyogram.

Authors:  Marianne Schmid Daners; Sophie Hall; Simon Sündermann; Nikola Cesarovic; Mareike Kron; Volkmar Falk; Christoph Starck; Mirko Meboldt; Seraina A Dual
Journal:  ASAIO J       Date:  2021-12-01       Impact factor: 3.826

7.  A Device Strategy-Matched Comparison Analysis among Different Intermacs Profiles: A Single Center Experience.

Authors:  Raphael Caraffa; Jonida Bejko; Massimiliano Carrozzini; Olimpia Bifulco; Vincenzo Tarzia; Giulia Lorenzoni; Daniele Bottigliengo; Dario Gregori; Chiara Castellani; Tomaso Bottio; Annalisa Angelini; Gino Gerosa
Journal:  J Clin Med       Date:  2022-08-20       Impact factor: 4.964

8.  Impact of Sacubitril/Valsartan on surfactant binding proteins, central sleep apneas, lung function tests and heart failure biomarkers: Hemodynamic or pleiotropism?

Authors:  Massimo Mapelli; Irene Mattavelli; Elisabetta Salvioni; Cristina Banfi; Stefania Ghilardi; Fabiana De Martino; Paola Gugliandolo; Valentina Mantegazza; Valentina Volpato; Christian Basile; Maria Inês Fiuza Branco Pires; Valentina Sassi; Benedetta Nusca; Carlo Vignati; Mauro Contini; Chiarella Sforza; Maria Luisa Biondi; Pasquale Perrone Filardi; Piergiuseppe Agostoni
Journal:  Front Cardiovasc Med       Date:  2022-09-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.